Hengrui Medicine (01276.HK): Fumarylacetic acid tigilizadine injection approved for clinical trials.

Zhtng Cijng APP News, Hng Ru Yyo (01276.HK) announced that Jiangsu Hng Ru Yyo Gfn Yuxin Gngs (hereinafter referred to as "the Company") has received the approval and issuance of the "Drug Clinical Trial Approval Notification" for Fmsun Ti Jl Dng Zhsh Y from the National Medical Products Administration (hereinafter referred to as "NMPA"), and will soon commence clinical trials.